NOVALGIN Meaning and
Definition
-
Novalgin, also known as metamizole sodium or dipyrone, is a pharmaceutical drug widely used as an analgesic (pain reliever) and antipyretic (fever reducer). It belongs to the class of medications called pyrazolones and acts by inhibiting the synthesis of certain substances responsible for pain and fever signals in the body.
The primary mechanism of action of Novalgin involves its ability to block the production of prostaglandins, which are chemical messengers involved in inflammation and pain signaling. By inhibiting the formation of these prostaglandins, Novalgin helps alleviate moderate to severe pain and reduce fever, making it an effective treatment for a wide range of conditions, including headache, toothache, postoperative pain, neuralgia, and high fever.
Novalgin is available in various forms, such as tablets, injections, and syrup, allowing for different methods of administration depending on the individual and their specific needs. The dosage of Novalgin varies depending on the age, weight, and medical condition of the patient, and it is typically administered only under the guidance of a healthcare professional.
Although generally well-tolerated, Novalgin may have potential side effects, including skin reactions, gastrointestinal disturbances, and, rarely, blood disorders. As with any medication, it is essential to use Novalgin as prescribed and to consult a healthcare provider for appropriate advice and guidance.
Common Misspellings for NOVALGIN
- bovalgin
- movalgin
- jovalgin
- hovalgin
- nivalgin
- nkvalgin
- nlvalgin
- npvalgin
- n0valgin
- n9valgin
- nocalgin
- nobalgin
- nogalgin
- nofalgin
- novzlgin
- novslgin
- novwlgin
- novqlgin
- novakgin
- novapgin
Etymology of NOVALGIN
The word "Novalgin" is a proprietary name used for a particular drug, known as metamizole or dipyrone in pharmaceutical terminology. The etymology of "Novalgin" is not readily available as it is a coined or created name specifically for branding purposes, rather than a derivative of its chemical composition or a preexisting term.
The drug itself, metamizole or dipyrone, was first synthesized in the 1920s by German pharmaceutical company Hoechst AG (now part of Sanofi). The origin of the name "Novalgin" is attributed to Hoechst AG, which introduced it as a trademark for metamizole when the drug was launched in the German market in 1922.
It is important to note that the etymology of proprietary drug names often does not possess any linguistic or historical significance, as their creation is primarily driven by marketing and branding strategies.
Infographic
Add the infographic to your website:
